Genome-wide association analysis identifies susceptibility loci for migraine without aura

Nature Genetics

Volumn 44, Issue 7, 2012, Pages 777-782

  Freilinger, Tobias ^a   Anttila, Verneri ^b,c   De Vries, Boukje ^d   Malik, Rainer ^a   Kallela, Mikko ^e   Terwindt, Gisela M ^d   Pozo Rosich, Patricia ^f,g   Winsvold, Bendik ^b,h   Nyholt, Dale R ⁱ   Van Oosterhout, Willebrordus P J ^d   Artto, Ville ^e   Todt, Unda ^j   Hämäläinen, Eija ^b,c   Fernández Morales, Jèssica ^b,g   Louter, Mark A ^d   Kaunisto, Mari A ^c,k   Schoenen, Jean ^l   Raitakari, Olli ^m   Lehtimäki, Terho ⁿ   Vila Pueyo, Marta ^g   Göbel, Hartmut ^o   Wichmann, Erich ^p   Sintas, Cèlia ^q,r   Uitterlinden, Andre G ^s   Hofman, Albert ^s   Rivadeneira, Fernando ^s   Heinze, Axel ^o   Tronvik, Erling ^t   Van Duijn, Cornelia M ^s   Kaprio, Jaakko ^c,u   Cormand, Bru ^q,r   Wessman, Maija ^c,k   Frants, Rune R ^d   Meitinger, Thomas ^p,v   Müller Myhsok, Bertram ^w   Zwart, John Anker ^h   Färkkilä, Markus ^e   MacAya, Alfons ^g   Ferrari, Michel D ^d   Kubisch, Christian ^j   Palotie, Aarno ^b,c,e,x   Dichgans, Martin ^a   Van Den Maagdenberg, Arn M J M ^d   more..

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c UNIVERSITY OF HELSINKI   (Finland)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^f HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^g UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^j UNIVERSITY OF ULM   (Germany)

^k FOLKHÄLSAN RESEARCH CENTER   (Finland)

^l UNIVERSITY OF LIÈGE   (Belgium)

^m TURKU UNIVERSITY HOSPITAL   (Finland)

ⁿ TAMPERE UNIVERSITY HOSPITAL   (Finland)

^o Kiel Pain and Headache Center   (Germany)

^p INSTITUTE OF EPIDEMIOLOGY   (Germany)

^q UNIVERSITY OF BARCELONA   (Spain)

^r CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^s ERASMUS MEDICAL CENTER   (Netherlands)

^t NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^u NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^v TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^w MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^x BROAD INSTITUTE OF MIT AND HARVARD   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASTN2 GENE; GENE; GENE LOCUS; GENE REPLICATION; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HUMAN; MAJOR CLINICAL STUDY; MEF2D GENE; MIGRAINE WITHOUT AURA; PHACTR1 GENE; POPULATION RESEARCH; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TGFBR2 GENE;

ADULT; CASE-CONTROL STUDIES; FEMALE; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-1; MADS DOMAIN PROTEINS; MALE; MICROFILAMENT PROTEINS; MIGRAINE WITHOUT AURA; MYOGENIC REGULATORY FACTORS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; TRPM CATION CHANNELS;

EID: 84862976129     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng.2307     Document Type: Article

References (49)

1. Launer, L.J., Terwindt, G.M. & Ferrari, M.D. The prevalence and characteristics of migraine in a population-based cohort: the GEM study. Neurology 53, 537-542 (1999). (Pubitemid 29382048)
2. Stovner, L.J., Zwart, J.A., Hagen, K., Terwindt, G.M. & Pascual, J. Epidemiology of headache in Europe. Eur. J. Neurol. 13, 333-345 (2006).
3. Stovner, L. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 27, 193-210 (2007). (Pubitemid 46354128)
4. Olesen, J., Lekander, I., Andlin-Sobocki, P. & Jönsson, B. Funding of headache research in Europe. Cephalalgia 27, 995-999 (2007). (Pubitemid 47296033)
5. Anttila, V. et al. Genome-wide association study of migraine implicates a common susceptibility variant on 8q22.1. Nat. Genet. 42, 869-873 (2010).
6. Chasman, D.I. et al. Genome-wide association study reveals three susceptibility loci for common migraine in the general population. Nat. Genet. 43, 695-698 (2011).
7. Dimas, A.S. et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325, 1246-1250 (2009).
8. Nica, A.C. et al. The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet. 7, e1002003 (2011).
9. Lin, X., Shah, S. & Bulleit, R.F. The expression of MEF2 genes is implicated in CNS neuronal differentiation. Brain Res. Mol. Brain Res. 42, 307-316 (1996). (Pubitemid 27035761)
10. Flavell, S.W. et al. Activity-dependent regulation of MEF2 transcription factors suppresses excitatory synapse number. Science 311, 1008-1012 (2006). (Pubitemid 43271729)
11. Aurora, S.K. & Wilkinson, F. The brain is hyperexcitable in migraine. Cephalalgia 27, 1442-1453 (2007). (Pubitemid 350150807)
12. Ferrari, M.D., Odink, J., Bos, K.D., Malessy, M.J. & Bruyn, G.W. Neuroexcitatory plasma amino acids are elevated in migraine. Neurology 40, 1582-1586 (1990). (Pubitemid 20351354)
13. Martínez, F., Castillo, J., Rodríguez, J.R., Leira, R. & Noya, M. Neuroexcitatory amino acid levels in plasma and cerebrospinal fluid during migraine attacks. Cephalalgia 13, 89-93 (1993). (Pubitemid 23116117)
14. Tottene, A. et al. Enhanced excitatory transmission at cortical synapses as the basis for facilitated spreading depression in Cav2.1 knockin migraine mice. Neuron 61, 762-773 (2009).
15. Flavell, S.W. et al. Genome-wide analysis of MEF2 transcriptional program reveals synaptic target genes and neuronal activity-dependent polyadenylation site selection. Neuron 60, 1022-1038 (2008).
16. Morrow, E.M. et al. Identifying autism loci and genes by tracing recent shared ancestry. Science 321, 218-223 (2008). (Pubitemid 351989087)
17. Pfeiffer, B.E. et al. Fragile X mental retardation protein is required for synapse elimination by the activity-dependent transcription factor MEF2. Neuron 66, 191-197 (2010).
18. Schytz, H.W. et al. PACAP38 induces migraine-like attacks in patients with migraine without aura. Brain 132, 16-25 (2009).
19. Markovics, A. et al. Pituitary adenylate cyclase-activating polypeptide plays a key role in nitroglycerol-induced trigeminovascular activation in mice. Neurobiol. Dis. 45, 633-644 (2012).
20. Goadsby, P.J., Lipton, R.B. & Ferrari, M.D. Migraine-current understanding and treatment. N. Engl. J. Med. 346, 257-270 (2002).
21. Lin, H.Y., Wang, X.F., Ng-Eaton, E., Weinberg, R.A. & Lodish, H.F. Expression cloning of the TGF-β type 2 receptor, a functional transmembrane serine/threonine kinase. Cell 68, 775-785 (1992).
22. Law, C. et al. Clinical features in a family with an R460H mutation in transforming growth factor β receptor 2 gene. J. Med. Genet. 43, 908-916 (2006). (Pubitemid 46080187)
23. Rist, P.M., Diener, H.C., Kurth, T. & Schürks, M. Migraine, migraine aura, and cervical artery dissection: a systematic review and meta-analysis. Cephalalgia 31, 886-896 (2011).
24. Allen, P.B., Greenfield, A.T., Svenningsson, P., Haspeslagh, D.C. & Greengard, P. Phactrs 1-4: a family of protein phosphatise 1 and actin regulatory proteins. Proc. Natl. Acad. Sci. USA 101, 7187-7192 (2004). (Pubitemid 38596464)
25. Greengard, P., Allen, P.B. & Nairn, A.C. Beyond the dopamine receptor: the DARPP-32/protein phosphatase-1 cascade. Neuron 23, 435-447 (1999). (Pubitemid 29359916)
26. Jarray, R. et al. Depletion of the novel protein PHACTR-1 from human endothelial cells abolishes tube formation and induces cell death receptor apoptosis. Biochimie 93, 1668-1675 (2011).
27. Myocardial Infarction Genetics Consortium. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat. Genet. 41, 334-341 (2009).
28. Tietjen, G.E. Migraine as a systemic vasculopathy. Cephalalgia 29, 987-996 (2009).
29. Wilson, P.M., Fryer, R.H., Fang, Y. & Hatten, M.E. Astn2, a novel member of the astrotactin gene family, regulates the trafficking of ASTN1 during glial-guided neuronal migration. J. Neurosci. 30, 8529-8540 (2010).
30. DaSilva, A.F., Granziera, C., Snyder, J. & Hadjikhani, N. Thickening in the somatosensory cortex of patients with migraine. Neurology 69, 1990-1995 (2007). (Pubitemid 350145091)
31. Kruit, M.C. et al. Migraine as a risk factor for subclinical brain lesions. J. Am. Med. Assoc. 291, 427-434 (2004). (Pubitemid 38129746)
32. Proudfoot, C.J. et al. Analgesia mediated by the TRPM8 cold receptor in chronic neuropathic pain. Curr. Biol. 16, 1591-1605 (2006). (Pubitemid 44233290)
33. Caspani, O., Zurborg, S., Labuz, D. & Heppenstall, P.A. The contribution of TRPM8 and TRPA1 channels to cold allodynia and neuropathic pain. PLoS ONE 4, e7383 (2009).
34. d'Agostino, V.C., Francia, E., Licursi, V. & Cerbo, R. Clinical and personality features of allodynic migraine. Neurol. Sci. 31 (suppl. 1), S159-S161 (2010).
35. Lillis, A.P., van Duyn, L.B., Murphy-Ullrich, J.E. & Strickland, D.K. LDL receptor-related protein 1: unique tissue-specific functions revealed by selective gene knockout studies. Physiol. Rev. 88, 887-918 (2008).
36. May, P. et al. Neuronal LRP1 functionally associates with postsynaptic proteins and is required for normal motor function in mice. Mol. Cell. Biol. 24, 8872-8883 (2004). (Pubitemid 39313893)
37. Russell, M.B., Rasmussen, B.K., Fenger, K. & Olesen, J. Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population. Cephalalgia 16, 239-245 (1996). (Pubitemid 26189249)
38. Kallela, M., Wessman, M., Havanka, H., Palotie, A. & Färkkilä, M. Familial migraine with and without aura: clinical characteristics and co-occurrence. Eur. J. Neurol. 8, 441-449 (2001). (Pubitemid 34203436)
39. Frazer, K.A. et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449, 851-861 (2007). (Pubitemid 47598626)
40. Teo, Y.Y. et al. A genotype calling algorithm for the Illumina BeadArray platform. Bioinformatics 23, 2741-2746 (2007). (Pubitemid 350048339)
41. Howie, B.N., Donnelly, P. & Marchini, J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 5, e1000529 (2009).
42. Altshuler, D.M. et al. Integrating common and rare genetic variation in diverse human populations. Nature 467, 52-58 (2010).
43. Mägi, R. & Morris, A.P. GWAMA: software for genome-wide association meta-analysis. BMC Bioinformatics 11, 288 (2010).
44. Cochran, W.G. The combination of estimates from different experiments. Biometrics 10, 101-129 (1954).
45. Higgins, J.P. & Thompson, S.G. Quantifying heterogeneity in a meta-analysis. Stat. Med. 21, 1539-1558 (2002). (Pubitemid 34746062)
46. Ioannidis, J.P., Patsopoulos, N.A. & Evangelou, E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS ONE 2, e841 (2007).
47. DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control. Clin. Trials 7, 177-188 (1986). (Pubitemid 17189972)
48. Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559-575 (2007). (Pubitemid 47330214)
49. Stranger, B.E. et al. Population genomics of human gene expression. Nat. Genet. 39, 1217-1224 (2007). (Pubitemid 47482691)